Basic Cardiovascular Sciences 2025  /  Emerging Cardiovascular Translational Technologies  /  Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy
Logo

American Heart Association

  84
  0

Final ID:

Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy

  • Murry, Charles  ( University of Southern California , Los Angeles , California , United States )
    • Author Disclosures:
    Charles Murry: No Answer
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

Emerging Cardiovascular Translational Technologies

Friday, 07/25/2025 , 08:00AM - 09:15AM

General Session

More abstracts on this topic:
Preclinical characterization of CK-4021586, a new class of cardiac myosin inhibitors, for the treatment of heart failure with preserved ejection fraction

Sarkar Saswata Sankar, Archer Benjamin, Dorion William, Rupert Cassady, Abi-gerges Najah, Rodriguez Janette, Martin Desirae, Derosier Andre, Edell Samantha, Wu Yangsong, Yco Lisette, Redd Meredith, Murphy Anne, Morgan Bradley, Malik Fady, Hartman James, Hwee Darren, Bat-erdene Anand, Kim Leo, Chuang Chihyuan, Li Xia, Dau Viet

Stem Cells, Genomics, and AI for Drug Discovery

Wu Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available